Trademark Application for “KEYNOTE” Filed by Merck

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for

1 min Read
07.9.2014

By Equities News Author

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “KEYNOTE” by Christopher Bolinger, representing Merck. This application was made available to the public on July 01, 2014 (see also Trademarks).
The international trademark goods and services class code for this trademark application is 044.
The serial number for this application is 86195946.
As submitted by the applicant, this trademark application relates to the following goods and services: Medical information relating to oncology.
The owner/registrar information for this application is: Christopher Bolinger, Merck, 126 E Lincoln Ave, Rahway, NJ 07065-4646.
Keywords for this news article include: Merck, Trademarks.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

Investing & Finance

Everything an Investor Needs to Know About The Petrodollar and, Um, The Petroyuan

Private Wireless Has More than Earned Its Status as a Growth Sector. Here’s Why

Market Implications Are Significant as U.S. – China Relations Falter

How We Use Assumptions and Why They Matter

When U.S. Stocks Pass the Torch and What That Might Look Like

Semiconductor Stocks Rebound, But Sector Still Has Issues

With pandemic-induced supply chain bottlenecks receding, semiconductor stocks have been riding a bullish trend, making higher lows and higher highs.

It’s Easy For Leaders to Play the Blame Game. Don’t.

To say the current situation isn’t pretty now seems an understatement, and it’s likely to remain chaotic for a while. Which is why it’s so important for leaders of all kinds not to fall prey to the very human tendency to go negative.

Pharma M&A Shows an Industry Looking to Specialize

Two of the biggest acquisitions in the industry confirm a trend in pharma M&A: The big players are trawling for opportunities in the rare-disease space.

This Prestigious Bank Is Down 90% — Is Now the Time to Buy?

Bargain-hunting friends of mine have been asking: “Should I buy First Republic?” After all, First Republic is prestigious. Facebook founder Mark Zuckerberg got a mortgage there. Dozens of customer surveys rate its satisfaction scores higher than super-brands like Apple and Ritz-Carlton.

Tradier Inc.

3 min Read
03.31.2023

Tradier Inc.
3 min Read
03.31.2023

Trademark Application for “KEYNOTE” Filed by Merck

By Equities News Author

Everything an Investor Needs to Know About The Petrodollar and, Um, The Petroyuan

Private Wireless Has More than Earned Its Status as a Growth Sector. Here’s Why

Market Implications Are Significant as U.S. – China Relations Falter

How We Use Assumptions and Why They Matter

When U.S. Stocks Pass the Torch and What That Might Look Like

Semiconductor Stocks Rebound, But Sector Still Has Issues

It’s Easy For Leaders to Play the Blame Game. Don’t.

Pharma M&A Shows an Industry Looking to Specialize

This Prestigious Bank Is Down 90% — Is Now the Time to Buy?

Recession Odds Rising (Plus: Jay Powell, Meet Sal Dali)

Qualcomm Looks to The Horizon and Sees AI

Semiconductor Stocks Rebound, But Sector Still Has Issues

Sign up For our Newsletter

SITEMAP

Contact